pharmaceuticals

NATCO Pharma Limited (NATCOPHARM) Q3 FY23 Earnings Concall Transcript

● Feb 12, 2023

NATCO Pharma Limited (NSE:NATCOPHARM) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Rajesh Chebiyam — Executive Vice President of Crop...

ABBOTT INDIA LTD Ltd. (NSE: ABBOTTINDIA): Q3 FY23 Results Out; Total Income Rises 10% YoY

● Feb 10, 2023

Abbott India Limited (NSE:ABBOTTINDIA) is a subsidiary of Abbott Laboratories, a multinational healthcare company. It was established in India in...

Alkem Laboratories Ltd. (NSE: ALKEM): Q3 FY23 Results Out; Total Income Rises 15% YoY

● Feb 10, 2023

Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company that specializes in developing, manufacturing, and marketing of pharmaceutical and nutraceutical products. The...

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY23 Earnings Concall Transcript

● Feb 10, 2023

JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: Jason D’Souza — Vice President, Investor...

Piramal Pharma Ltd (PPLPHARMA) Q3 FY23 Earnings Concall Transcript

● Feb 9, 2023

Piramal Pharma Ltd (NSE: PPLPHARMA) Q3 FY23 Earnings Concall dated Feb. 09, 2023 Corporate Participants: Gagan Borana — General Manager, Investor Relations...

Earnings Summary Of Gland Pharma For Q3 FY23

● Feb 9, 2023

Gland Pharma Limited (NSE: GLAND) is an Indian pharmaceutical company that specialises in producing high-quality, low-cost generic medications. The company...

Gland Pharma’s Acquisition Of Cenexi & Decline In Lead Product’s Market Share

● Feb 9, 2023

Gland Pharma Limited (NSE: GLAND) is a major player in the Indian pharmaceutical market, specialising in the production and sale...

Piramal Enterprises Ltd Q3 FY23 Earnings Conference Call Insights

● Feb 9, 2023

Key highlights from Piramal Enterprises Ltd (PEL) Q3 FY23 Earnings Concall Q&A Highlights: [00:16:30] Abhijit Tibrewal from Motilal Oswal asked...

Granules India Limited Q3 FY23; PAT Jumped Up To 124 Crore

● Feb 8, 2023

Granules India Limited (NSE: GRANULES) reported Revenue from Operations for Q3 FY23 of ₹1,146.12 Crore up from ₹996.76 Crore year...

SUVEN PHARMACEUTICALS LTD (SUVEN) Q3 FY23 Earnings Concall Transcript

● Feb 7, 2023

SUVEN PHARMACEUTICALS LTD (NSE:SUVEN) Q3 FY23 Earnings Concall dated Feb. 07, 2023. Corporate Participants: Rishab Barar — Investor Relations Venkat Jasti — Managing Director...